Freshpet (FRPT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Neutral
FRPT Zacks Investment Research — July 28, 2025Freshpet (FRPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hagerty, Inc. (HGTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Positive
HGTY Zacks Investment Research — July 28, 2025Hagerty (HGTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Diamondback Energy (FANG) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Positive
FANG Zacks Investment Research — July 28, 2025Diamondback (FANG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Helios Technologies (HLIO) to Report a Decline in Earnings: What to Look Out for — Negative
HLIO Zacks Investment Research — July 28, 2025Helios Technologies (HLIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ichor Holdings (ICHR) Reports Next Week: Wall Street Expects Earnings Growth — Positive
ICHR Zacks Investment Research — July 28, 2025Ichor Holdings (ICHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy? — Positive
IDXX Zacks Investment Research — July 28, 2025Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hims & Hers Health, Inc. (HIMS) Reports Next Week: Wall Street Expects Earnings Growth — Positive
HIMS Zacks Investment Research — July 28, 2025Hims & Hers Health (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amazon Q2 Preview: Can Prime Day Hype And AI-Fueled AWS Drive A Big Earnings Beat? — Positive
AMZN Seeking Alpha — July 28, 2025Amazon.com, Inc. is attractively valued, but I rate it Market Perform/Hold due to mixed signals in fundamentals and technicals ahead of Q2 earnings. Commerce growth is decelerating and I expect some volume gains to be offset by falling average selling prices. We should not trust the bullish headlines on Amazon Prime Day's performance. AWS margin improvements (likely from AI-driven headcount efficiencies) are a positive, but capex upgrades may lead to FCF margin erosion risk. We must seek clarity on proof of ROI.
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy? — Positive
INSP Zacks Investment Research — July 28, 2025Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JBT Marel (JBTM) Reports Next Week: Wall Street Expects Earnings Growth — Positive
JBTM Zacks Investment Research — July 28, 2025JBT (JBTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Ardelyx (ARDX) Q2 Earnings Expected to Decline — Negative
ARDX Zacks Investment Research — July 28, 2025Ardelyx (ARDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MVB Financial (MVBF) to Report Q2 Results: What Awaits? — Neutral
MVBF Zacks Investment Research — July 28, 2025MVB Financial (MVBF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Krystal Biotech, Inc. (KRYS) to Report Q2 Results: Wall Street Expects Earnings Growth — Positive
KRYS Zacks Investment Research — July 28, 2025Krystal Biotech (KRYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Palantir Technologies Inc. (PLTR) Earnings Expected to Grow: Should You Buy? — Neutral
PLTR Zacks Investment Research — July 28, 2025Palantir Technologies (PLTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CPI Card Group Inc. (PMTS) Earnings Expected to Grow: What to Know Ahead of Q2 Release — Neutral
PMTS Zacks Investment Research — July 28, 2025CPI Card Group (PMTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Palomar (PLMR) Earnings Expected to Grow: Should You Buy? — Positive
PLMR Zacks Investment Research — July 28, 2025Palomar (PLMR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate SiriusPoint (SPNT) to Report a Decline in Earnings: What to Look Out for — Negative
SPNT Zacks Investment Research — July 28, 2025SiriusPoint (SPNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Trex (TREX) Q2 Earnings Expected to Decline — Negative
TREX Zacks Investment Research — July 28, 2025Trex (TREX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Primoris Services (PRIM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Positive
PRIM Zacks Investment Research — July 28, 2025Primoris Services (PRIM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth — Positive
VRTX Zacks Investment Research — July 28, 2025Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
